Oberguggenberger, A., Meraner, V., Sztankay, M., Beer, B., Weigel, G., Oberacher, H., . . . Hubalek, M. (2017). Can we use gonadotropin plasma concentration as surrogate marker for BMI-related incomplete estrogen suppression in breast cancer patients receiving anastrozole? BMC Cancer.
Citação norma ChicagoOberguggenberger, A., et al. "Can We Use Gonadotropin Plasma Concentration As Surrogate Marker for BMI-related Incomplete Estrogen Suppression in Breast Cancer Patients Receiving Anastrozole?" BMC Cancer 2017.
Citação norma MLAOberguggenberger, A., et al. "Can We Use Gonadotropin Plasma Concentration As Surrogate Marker for BMI-related Incomplete Estrogen Suppression in Breast Cancer Patients Receiving Anastrozole?" BMC Cancer 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.